Conference day one – Tuesday 19 April 2016

Moving pharma supply chain forward, how increased visibility can drive operational excellence and patients safety. Given global trends such as more patients accessing new treatments and the shift to biologicals, how can we mitigate risk in the supply chain today and in the future?

---

Tailored content for: VP/Director Supply Chain, Business Process/Project

---

Tailored content for: VP/Director Supply Chain, Planning, IT, Sourcing

---

Tailored content for: Director Logistics, Transportation, Warehousing, Distribution, Quality, Sourcing

---

Manfred is directly responsible for orchestrating and overseeing technical transfer projects of Roche worldwide. Within his role, Manfred manages the 30 licensee partnerships and 10 product divestment partners worldwide. Manfred oversees the integration of acquired businesses as well as business and brand divestitures, where his vast experience in negotiating, establishing and managing the technical side of licensee relationships ensures a smooth and efficient transition.

•What would true collaboration entail?
•What information can 3PLs and wholesalers realistically share with pharma?
•What ground rules can you implement to avoid sharing competitive information?
•What are the main areas in which you could share efficiencies?

---

---

---

Jan oversees the overall supply chain management within the European Technology division of Astellas, including planning and inventory management, logistics and distribution, contract manufacturing supplies, procurement of direct materials, artwork and master data management. Jan has also developed highly successful strategies in developing new manufacturing facilities, ERP (SAP) implementations, merger and plant divestments, outsourcing of manufacturing activities and contract manufacturing in Russia.

•What strategies can you put in place to handle increasing price pressure: New ways to manage your S&OP, upstream planning processes, artwork management and master data
•How can you restructure your regional supply chain organisation to optimize their performance?
•How can you optimize the relationship with your 3rd party providers: 3PLs, distribution services, CMOs and direct material suppliers
•How can you manage supply chain uncertainty whilst your product portfolio is undergoing a change?
•What approaches can you take to forecasting with increasingly volatile markets?

---

---

Mike is the global process owner for logistics - directly responsible for serving as the global process owner for warehouse, shipping and distribution operations. He is in charge of developing strategy and organizational structure for the internal and external distribution networks encompassing global operational polices and standards. Mike has over 25 years of experience in the pharmaceutical industry including 22 years at Eli Lilly, ideally placing him to discuss the best strategies for governance of providers.

•How to prioritise what to include in the corporate action plan •What strategies can you put in place to minimise misinterpretations of the plan?
•What should you prioritise to remain compliant whilst controlling cost?
•How can you encourage buy-in from key stakeholders across the business?

---

•Examining the results of the latest PHARMA Management Radar survey
• To what extent do pharma companies already apply segmentation? • What are the leading-edge segmentation strategies & models?
• Benefits & the road to segmentation

---

---

• Understanding why context is crucial to cross-functional root cause analytics
• How to use actionable diagnostics to improve supply chain performance
• Exploring how prescriptive and predictive analytics are the logical evolution of cloud analytics
• Taking advantage of scalability by allowing all levels to leverage a company's "big data"

---

---

•How does the solution help to meet EU GDP guidelines?
•Which product-type does this technology provide the best solution for?
•Which regions does this technology provide the best solution for? •To what extent can this product integrate with other solutions?

---

Planning improvement is nowadays often driven by technology: better APS systems, sensors and measuring equipment connected over the internet and seamless information sharing via EDI kind of protocols. However, technology is not the only solution. It can only be as good as the people, the processes and how they are organized. This is the topic for the EyeOn master class: “how to organize your planning organization”.

Many companies are struggling with finding the best organizational set-up and are looking for best practices to improve. During this lunch-session (lunch will be served), we will present, based on our research and industry experience, the key drivers that determine the fit for purpose organizational set-up. Next to that, we will discuss the required skill set for the various roles within a supply chain organization.

We are looking forward meeting you in our interactive master class!

---

---

Many companies are struggling with finding the best organizational set-up and are looking for best practices to improve. During this lunch-session (lunch will be served), we will present, based on our research and industry experience, the key drivers that determine the fit for purpose organizational set-up. Next to that, we will discuss the required skill set for the various roles within a supply chain organization.

We are looking forward meeting you in our interactive master class!

---

---

Heiske heads up the introduction of new Amgen medical products in Europe for Operations including supply chain design and implementation, SKU strategy, launch/ drug in channel strategy, manufacturing, logistics & distribution, customer support and life cycle management. Heiske focuses on problem solving and execution to implement new strategies and ensure new products reach the market quickly and efficiently.

Els is accountable for new product introduction, product life cycle management and product supply planning for the EEMEA region. In her role, Els is currently investigating how differentiation between customer requirements can help optimise supply chain for the customer, with a focus on how the market is built to define her supply chain strategies.

• What are the best ways to segment your customers to determine your optimum supply chain?
• How can you best work with wholesalers and distributors in the region to implement customer segmentation?
• How can you define an effective strategy for high value products?
• How can you make the right decisions for a region where shelf life requirements are extreme and you cannot meet customer requirements through relying on high inventory?

---

---

• What steps can you take to ensure your cloud solution is secure?

• How to set up the Internet of Things (IoT) with your cloud solution?

• How can you use your cloud capability to integrate with 3/4PLs and CMOs?

• To what extent are there any regulatory barriers to using cloud?

---

---

This panel brings together key temperature control decision makers from top pharma companies along with feedback from a leading airport.
•What strategies can you put in place to ensure your service providers remain compliant?
•How can you encourage the 3PLs to interpret and meet GDP guidelines independently of pharma oversight?
•How can you ensure all manufacturing sites and CMOs have the same degree of understanding of the guidelines?
•What are the best ways for working with 3PLs to choose optimal temperature control solutions?

---

---

---

---

Kim leads his team of 80 in heading up Pfizer’s global European logistics centre, where he focuses on continuous improvement and business excellence, including Six Sigma and LEAN tools. Through these tools and his strategies, Kim has achieved a 3 fold output increase and 75% lead time reduction in process times. •How can you break down silos across different teams and regions?
•How can you best convince teams of the benefits of a change in process?
•What cultural considerations should you take on board?
•Tips and tricks on how to motivate teams who are reluctant to change

---

---

---

•How can you best integrate working with your 3PL following an acquisition?
•How to work with your 3PL to adapt your supply chain for direct-to-home delivery
•What does your 3PL need to know as commercial structures change?
•How to adapt your supply chain along with your 3PL when moving into new regions and therapies

---

• Overcoming the challenges of supply planning in a complex bio-pharma environment
• How to improve supply chain visibility
• What are the main steps taken to successfully select the right software?
• Examining business drivers that led to the selection of Kinaxis RapidResponse as the software component of Gilead’s supply planning solution

---

• Outlining in which countries you can implement the risk based approach to temperature control

• What methods work best to effectively assess risk based on product type?

• How do you effectively communicate your risk based approach methods to 3rd party providers?

• How can you document your risk based approach correctly for the regulators?

---

---

---

An exciting real-life case study with Janssen Pharmaceuticals and Swisslog.

• How to manage the requirements of an increasingly global business
• How can factory intralogistics solutions help to increase your foot print in emerging countries?
• How to develop solutions to be used successfully in new facilities
• What has been learned and what would be done differently next time?

---

---

Beyond Visibility: Achieving end to end clarity for supply chain decision-making
Robert Neeser, Senior Vice President, Trax Technologies

Advanced planning systems
Arie Moruanx, Global Surgery Planning Excellence Director, Johnson & Johnson

How to leverage best practice to bring your supply chain to the next level of excellence
Kamaljit Hunjan, SVP Global Operations, CEVA Logistics Heiko Bohm, VP EMEA Sales, CEVA Logistics

From visibility to optimization: How to use algorithm based intelligence to transform your global supplier, production and warehouse network into an optimized end-to-end supply chain
Prof. Dr. Tamer Ünal, Founder and CTO, ICRON Technologies

---

---

---

---

---

5min Showcase: Temperature Control Solution by Yann Martin, Global Sales Director, Emball'iso

---

---

•What are the specific requirements for temperature monitoring
•How you cooperate with the governmental entities to design the cold chain process?
•What are the best ways to manage extreme heat or freezing conditions?
•How do you decide which temperature control solutions to invest in?
•What are the main lessons learned from experience so far?

Choose from:
Table 1: Middle East & Saudi Arabia-
Simona Vatzova, Associate Director International Freight & Compliance, Actavis
Table 2: India -
Robert-Jan van den Bos, Director Supply Chain - Global Logistics, Amgen & Richard Ettl, CEO, SkyCell

---

---

---

---

---

Eduardo leads global teams in defining and implementing strategy for global launches and commercial supply in different therapeutic areas. In his role, Eduardo is a key representative of Manufacturing and Supply Chain in different programs, from development to commercialization, and focuses on integrating manufacturing and supply chain strategy with product’s strategy, ensuring speed to market and maximum revenue and profitability.

•How can you best work with R&D, commercial, IT and manufacturing to optimise time to market?
•What methods can you use to coordinate the launch process across different markets?
•What methods can you use to support maximizing revenue during launch process?
•What are the main differences depending on whether the product is owned by your company, a partner product or in-licensed?

---

Markus Hasselblatt currently manages divestment and licensing partnerships on behalf of Roche. In this role he is accountable for all operations aspects of programs he manages. Makrus has identifies strategies for success and plans, executes, and delivers technically complex projects and products on schedule throughout the transactions, which are of high financial significance for the involved parties.

•How can you best communicate and exchange information with your divestment partner?
•How can you rapidly set up supply planning and execution processes?
•How do you agree on which processes and structures to keep in place and what to change?
•How do you determine new manufacturing requirements – if any?
•How can you manage the product switching from the seller to the buyer – in each territory?

---

---

How to overcome some challenges in efficiency in light of increased and diverse regulations and risk & excursion management
How to bridge between packaging solutions and handling procedures to increase the reliability of your supply chain
How to use an integrated telemetry platform to overcome the challenge of gaps in visibility to support the path of excellence in pharma supply chain, allow accelerated improvement and improve collaborations across the industry

---

•Outlining the country specific requirements for temperature control •How you cooperate with the governmental entities in sub-saharan Africa?
•Examining the best ways to manage extreme heat conditions
•What are the main lessons learned from experience so far?

---

---

---